Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00045097 · ClinicalTrials.gov registry record · Phase 2
Ixabepilone in Treating Patients With Locally Advanced or Metastatic Breast Cancer
A Phase 2 study, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- Phase 2
- Development phase
NCT00045097: Completed Phase 2 study, sponsored by National Cancer Institute (NCI).
NCT00045097 is a Phase 2 study that has completed, run by National Cancer Institute (NCI). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00045097, a Phase 2 study, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying how well ixabepilone works in treating patients with locally advanced or metastatic breast cancer.
Interventions
- DRUG ixabepilone
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-05 |
| Est. Completion | 2007-07 |
| Phase | Phase 2 |
What the finished NCT00045097 record still lists
NCT00045097 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which ixabepilone is the first listed.
NCT00045097 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00045097 about?
NCT00045097 is a clinical study titled "Ixabepilone in Treating Patients With Locally Advanced or Metastatic Breast Cancer". RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying how well ixabepilone works in treating patients with locally advanced or metastatic breast cancer.
What is the current status of trial NCT00045097?
This trial is currently completed. It is a Phase 2 study. The study started on 2002-05. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00045097?
The interventions under investigation include: ixabepilone (DRUG).
Who is sponsoring clinical trial NCT00045097?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia